Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2025-12-28 @ 3:58 AM
Study NCT ID:
NCT05085561
Status:
COMPLETED
Last Update Posted:
2025-08-06
First Post:
2021-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Sponsor:
Recursion Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-08
First Submit QC Date:
None
Study First Post Date:
2021-10-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-01
Last Update Post Date:
2025-08-06
Last Update Post Date Type:
ACTUAL